Hospitals need to start thinking about ways to build patients' trust in generative AI in order for the healthcare industry to fully harness the technology's potential. They can do this through methods like having transparent conversations, asking for patients' consent to use the tools and training models on internal data, experts said.
Geron Corporation's Rytelo is now FDA approved for treating anemia caused by myelodysplastic syndromes. The new drug will compete against Reblozyl, a blockbuster Bristol Myers Squibb medicine.
Samaritan provides financial and social support to those without a home. The company was recently crowned winner of the payer/provider track of MedCity News' INVEST Pitch Perfect contest.
In this episode, we talk about recent stumbles in primary and virtual care from Walmart, Walgreens, Optum. We also discuss cybersecurity in healthcare and talk about which healthcare sector.
No comments